Research and Markets: Closed Drug Transfer Systems. Therapeutic Markets, Strategies and Outlook

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/fcn5rp/closed_drug) has announced the addition of the "Closed Drug Transfer Systems. Therapeutic Markets, Strategies and Outlook" report to their offering.

“Closed Drug Transfer Systems. Therapeutic Markets, Strategies and Outlook”

The administration of drugs deemed hazardous to humans has been receiving increasing amounts of scrutiny in recent years as the dangers of these substances become more clearly understood. For caregivers and their patients, the therapeutic area that is at the forefront of attempts to mitigate exposure to cytotoxic drugs is clinical oncology, a field that - in spite of promising new drugs based on therapeutic antibodies - continues to rely heavily on antineoplastics, a class that includes alkylating agents and antimetabolites, to treat a wide range of cancers. Regulatory and industry efforts to create standards and procedures designed to protect workers and patients from accidental and incidental exposure to cytotoxics are being driven by data that suggests a causal link between exposure and health issues. Studies of nurses who work with cytotoxic drugs on a regular basis have found a statistically higher rate of spontaneous abortion. Several companies are responding to this unmet need by commercializing devices for closed transfer of these drugs. As the market evolves and user acceptance increases, so too will the impact of these products on oncology therapy protocols and drug delivery.

Highlights

- Analyzes the impact of drug toxicity and safety factors on therapeutic oncology market segments, market dynamics and market demographics

- Provides detailed analysis of closed drug transfer products for the handing of cytotoxic drugs

- Analyzes demand drivers and competitive factors influencing closed drug transfer adoption

-Charts product data and provides forecasts to 2017

- Profiles closed drug transfer device participants, their product development activities, business strategies, and corporate alliances and affiliations

Topics Covered

Executive Summary

Oncology Therapeutics Market Dynamics

Therapeutic Trends and Issues

The Administration of injectable/Infusable Antineoplastics

Drug Packaging and Administration Technology

Closed Drug Transfer Market Drivers

Competitive Landscape

Risk Factors

Closed Drug Transfer Design Factors

Key System Design Elements

Human Engineering/Ergonomics